Defective ribosome assembly impairs leukemia progression in a murine model of acute myeloid leukemia Cell Rep
Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants NPJ Genom Med
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance J Clin Oncol
Severe ischemia and reperfusion injury induces epigenetic inactivation of LHX1 in kidney progenitor cells after kidney transplantation Am J Transplant
The effects of ENDOG on lipid metabolism may be tissue-dependent and may not require its translocation from mitochondria Nat Commun
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial Lancet Haematol
A multi-center, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma Haematologica